Rare diseases
Investigational molecules
Locations
Back to France977 clinical trials in STRASBOURG, Alsace, France across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Durvalumab with Chemotherapy and Radiotherapy for Patients with Unresectable Esophageal Cancer
FranceStudy of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration
FranceStudy of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma
FranceStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
FranceStudy Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer
FranceStudy on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer
FranceStudy of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer
FranceStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
FranceStudy of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
FranceStudy of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer
FranceStudy on Neflamapimod for Patients with Dementia with Lewy Bodies
FranceStudy of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on head and neck cancers, bladder cancer, and multiple myeloma. Novel therapeutic approaches combining immunotherapy with established treatments are being evaluated for improved patient outcomes.
Innovative combination therapies are being tested to enhance treatment efficacy while maintaining patient safety.
Comprehensive research into multiple sclerosis, essential tremor, and ADHD. Studies are evaluating both new and existing medications for improved symptom management and disease control.
Advanced neuroimaging techniques are being utilized to understand treatment effects on brain circuits.
Investigating new treatments for Crohn's disease, Sjögren's Syndrome, and Myasthenia Gravis. Research focuses on innovative therapeutic approaches including microbiota transplantation and targeted immunotherapies.
These trials aim to improve disease management and patient quality of life through targeted interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
